University Hospital Southampton NHS Foundation Trust is an NHS foundation trust which operates the Southampton General Hospital, the Princess Anne Hospital, Southampton Children’s Hospital, and the New Forest Birth Centre at Ashurst, Hampshire.

During the past decade, Southampton University Hospitals NHS Trust conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 10 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southampton University Hospitals NHS Trust" #1 sponsor was "University Hospital Southampton NHS Foundation Trust" with 4 trials, followed by "Celgene" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "University of Birmingham" with 2 trials sponsored and "University of Southampton" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southampton University Hospitals NHS Trust" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "University Hospital Southampton NHS Foundation Trust" with 3 trials as a collaborator, "American College of Rheumatology" with 1 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Southampton University Hospitals NHS Trust" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Crohn Disease" (2 trials), "Lymphoma" (2 trials), "Malnutrition" (2 trials) and "Acute Leukaemia" (1 trials). Many other conditions were trialed in "Southampton University Hospitals NHS Trust" in a lesser frequency.

Most popular intervention types in "Southampton University Hospitals NHS Trust" are "Drug" (17 trials), "Biological" (5 trials), "Other" (5 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "AZD1222" (1 trials), "AZD5363" (1 trials), "Abbott Sensor Based Glucose Monitoring System" (1 trials) and "Adalimumab (40 mg)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southampton University Hospitals NHS Trust" are 28 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Southampton University Hospitals NHS Trust". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Southampton University Hospitals NHS Trust, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southampton University Hospitals NHS Trust, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".